Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review
{{output}}
Rationale: Preemptive pharmacogenetic (PGx) testing offers a promising approach to personalized antidepressant treatment by identifying genetic variations influencing drug metabolism. By focusing on CYP2D6 and CYP2C19 genes, this... ...
